Furthermore, the CD4 compartment has been positively associated with response to ICI therapy (41–43), and a recent study in MCPyV-negative MCC even showed a positive association between neoantigen-specific CD4+ T cells in response to PD-1 blockade (44). This evidence concerns the gene CD4 and Merkel cell skin cancer.